Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Sep;53(5):1010-3.
doi: 10.3349/ymj.2012.53.5.1010.

Postoperative nausea and vomiting after myringoplasty under continuous sedation using midazolam with or without remifentanil

Ji Su Jang  1 , Jun Ho Lee, Jae Jun Lee, Won Jae Park, Sung Mi Hwang, Soo Kyung Lee, So Young Lim
Affiliations

Postoperative nausea and vomiting after myringoplasty under continuous sedation using midazolam with or without remifentanil

Ji Su Jang et al. Yonsei Med J. 2012 Sep.

Abstract

Purpose: This prospective study evaluated the effects of continuous sedation using midazolam, with or without remifentanil, on postoperative nausea and vomiting (PONV) in patients undergoing myringoplasty.

Materials and methods: Sixty patients undergoing myringoplasty were sedated with midazolam in the presence of remifentanil (group MR), or after saline injection instead of remifentanil (group M).

Results: Three patients (10%) in group M complained of nausea; two vomited. Four patients (13%) in group MR complained of nausea and vomited within 24 h after surgery. Rescue drugs were given to the six patients who vomited. No significant difference was detected between the two groups regarding the incidence or severity of nausea, incidence of vomiting, or need for rescue drugs.

Conclusion: Midazolam-based continuous sedation can reduce PONV after myringoplasty. Compared with midazolam alone, midazolam with remifentanil produced no difference in the incidence or severity of nausea, incidence of vomiting, or need for rescue drugs.

PubMed Disclaimer

Conflict of interest statement

The authors have no financial conflicts of interest.

References

    1. Watcha MF. Postoperative nausea and emesis. Anesthesiol Clin North America. 2002;20:709–722. - PubMed
    1. Habib AS, Gan TJ. Evidence-based management of postoperative nausea and vomiting: a review. Can J Anaesth. 2004;51:326–341. - PubMed
    1. Kovac AL. Prevention and treatment of postoperative nausea and vomiting. Drugs. 2000;59:213–243. - PubMed
    1. Reinhart DJ, Klein KW, Schroff E. Transdermal scopolamine for the reduction of postoperative nausea in outpatient ear surgery: a double-blind, randomized study. Anesth Analg. 1994;79:281–284. - PubMed
    1. Honkavaara P. Effect of ondansetron on nausea and vomiting after middle ear surgery during general anaesthesia. Br J Anaesth. 1996;76:316–318. - PubMed